Cardiovascular Update: Mounjaro CV Win, Leadless Pacemakers, Pregabalin Risk and More
Discover the latest breakthroughs shaping the future of cardiovascular health! This week’s roundup brings you 11 powerful updates—from cutting-edge diagnostics and device innovations to bold clinical findings and digital health endorsements. Whether you’re a clinician, researcher, or healthcare enthusiast, these insights will keep you informed and ahead of the curve.
📌 In This Episode:
🩺 Noninvasive Screening Method Detects Hidden Heart Failure
🤝 Gentuity & GE HealthCare Collaborate to Advance Imaging Access
🧠 SGMC Earns 12th Consecutive Stroke Care Excellence Award
🛠️ APC Cardiovascular Expands Through Strategic Acquisition
⚠️ Pregabalin Linked to 85% Higher Risk of Heart Failure
🔬 New Electrowetting Imaging Tech Enhances Heart & Eye Diagnostics
💊 Mounjaro Delivers CV Benefits Over Trulicity in Major Diabetes Trial
📲 Omron Smart Devices Identify Early Heart Failure in One-Third of Users
✅ NHS Golden Jubilee Pioneers Advanced Leadless Pacemaker Technology
🏥 Takotsubo Syndrome Highlighted as a Silent ICU Risk
📱 NICE Recommends Six Digital Cardiac Rehab Platforms for Broader Access
📢 Stay Ahead in Cardiovascular Research!
✅ Like, share, and subscribe for weekly updates on cardiovascular innovation
#Cardiology #HeartHealth #HeartFailure #StrokeCare #DigitalHealth #Mounjaro #MedicalInnovation #Pacemaker #ClinicalResearch #NICE #Omron #LucidQuest #Takotsubo #CardiovascularUpdates